In this section

Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes

Peggs, K. et al. (2007) Reduced-intensity conditioning for allogeneic haematopoietic stem cell transplantation in relapsed and refractory Hodgkin lymphoma: impact of alemtuzumab and donor lymphocyte infusions on long-term outcomes. British Journal of Haematology, 139(1), pp. 70-80.

Full text not currently available from Enlighten.


Item Type:Articles
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:Parker, Dr Anne
Authors: Peggs, K., Sureda, A., Qian, W., Caballero, D., Hunter, A., Urbano-Ispizua, A., Cavet, J., Ribera, J., Parker, A., Canales, M., Mahendra, P., Garcia-Conde, J., Milligan, D., Sanz, G., Thomson, K., Arranz, R., Goldstone, A., Alvarez, I., Linch, D., Sierra, J., and Mackinnon, S.
College/School:College of Medical Veterinary and Life Sciences
Journal Name:British Journal of Haematology

University Staff: Request a correction | Enlighten Editors: Update this record

Deposit and Record Details